🇺🇸

US SEC Filing Intelligence

· daily

New Federal Contractors — June 21, 2026

Over a single day, June 21, 2026, two massive civilian-agency contracts totaling $3.04B were awarded, with zero defense-related obligations. The dominant theme is dual-use infrastructure: a $1.78B HHS contract to Leidos Biomedical Research for health/biodefense work, and a $1.26B DHS contract to Bollinger Shipyards for homeland security vessel construction. The highest-conviction signal is the sheer size and sole-source-like nature of both awards, suggesting deep incumbency or urgent mission need. A key risk is the lack of competition data—both awards may be sole-source or limited-competition, raising protest vulnerability and pricing opacity for investors.

2 total filings
· daily

Significant Contract Modifications ($10M+) — June 21, 2026

The two contracts analyzed, totaling $3.04 billion, are both classified as defense-related despite being awarded by civilian agencies—the Department of Health and Human Services (HHS) and the Department of Homeland Security (DHS)—highlighting a critical blurring of lines between civilian and defense spending. The dominant signal is a $1.78B award to Leidos Biomedical Research Inc. from HHS, representing the highest-conviction opportunity in the digest, while Bollinger Shipyards Lockport's $1.26B DHS contract underscores a separate maritime security theme. Both contracts carry bullish signals with a strong average signal strength of 7.0/10, but the absence of competitive or pricing data introduces execution and budget risks. Key watch items include potential continuing resolution (CR) impacts on HHS funding and DHS budget reauthorization timelines.

2 total filings
· daily

Contract Deobligations Alert — June 21, 2026

Over a single day on June 21, 2026, the government awarded $3.04B in total obligations, split entirely across civilian agencies (0% defense-related). The dominant theme is a massive $1.78B deobligation to Leidos Biomedical Research from HHS, paired with a $1.26B award to Bollinger Shipyards Lockport from DHS. Despite being labeled 'defense contracts' in the stream, both are civilian—Leidos supports biomedical research (likely NIH/NCI) and Bollinger builds Coast Guard vessels. The highest-conviction signal is the Leidos Biomedical award, which represents a material 58% of the aggregate and suggests sustained federal investment in health research infrastructure. A key risk is that both are deobligations (not new money), potentially indicating budget reallocations or contract closeouts rather than fresh spending, which could signal tightening civilian agency budgets.

2 total filings
· daily

Contract Option Exercises — June 21, 2026

The digest covers $3.04 billion in contract option exercises from June 21, 2026, split between two large awards, both classified as non-defense despite the agencies involved. The dominant theme is civilian agency spending, with the Department of Health and Human Services (HHS) accounting for $1.78 billion to Leidos Biomedical Research Inc. and the Department of Homeland Security (DHS) awarding $1.26 billion to Bollinger Shipyards Lockport, L.L.C. The highest-conviction signal is the sheer scale of the Leidos award, which represents a major biomedical research commitment. A key risk is the lack of pricing and competition details for both contracts, which obscures margin and protest risk.

2 total filings
· daily

All HHS Contracts — June 21, 2026

A single, massive $1.78B contract from the Department of Health and Human Services (HHS) to Leidos Biomedical Research Inc. dominates the period, representing 100% of the total obligation. This is a civilian agency award, not defense-related, and carries a bullish signal with high materiality (8/10). The contract's size suggests a critical, likely sole-source or follow-on award for biomedical research support, potentially tied to the National Cancer Institute or similar HHS entity. Key risks include execution risk given the large fixed-price or cost-plus nature (unknown pricing) and concentration risk for Leidos if this represents a significant portion of its revenue. Investors should watch for contract details (pricing type, competition status) and Leidos' upcoming earnings disclosures for revenue recognition guidance.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — June 21, 2026

Over a single-day period, two mega-contracts totaling $3.04B were awarded, both classified as defense-related but originating from civilian agencies (HHS and DHS), highlighting a critical trend of non-DoD agencies driving defense-adjacent spending. Leidos Biomedical Research Inc. secured the largest award at $1.78B from HHS, signaling sustained biodefense and health security priorities. Bollinger Shipyards Lockport won a $1.26B DHS contract, reinforcing homeland maritime security investments. Both signals are bullish with high materiality, but the lack of competitive or pricing data introduces execution and budget risk, especially under potential Continuing Resolution constraints. The dominant theme is civilian-agency defense spending, with Leidos and Bollinger as the highest-conviction beneficiaries.

2 total filings
· daily

High-Value Federal Grants ($5M+) — June 21, 2026

The digest covers $3.04 billion in high-value federal obligations from June 21, 2026, split between two civilian-agency contracts with no defense-related awards. The dominant theme is large-scale, single-award contracts to niche contractors: Leidos Biomedical Research Inc. secured a $1.78B award from HHS, while Bollinger Shipyards Lockport won a $1.26B award from DHS. Both contracts carry bullish signals with high materiality, but the lack of competition data and unknown pricing structures introduce execution and budget risk. The highest-conviction signal is the sheer size of the Leidos Biomedical award, which suggests deep incumbency in health research support, though the absence of defense exposure limits sector-wide defense upside. Key watch items include potential protest risk on the Bollinger shipbuilding award and the impact of continuing resolutions on HHS funding for Leidos Biomedical.

2 total filings
· daily

General Federal Contracts — June 21, 2026

The two contracts analyzed total $3.04 billion, both classified as civilian awards despite being labeled 'defense' in the raw data. The Department of Health and Human Services (HHS) dominates with a $1.78B award to Leidos Biomedical Research Inc., while the Department of Homeland Security (DHS) contributes $1.26B to Bollinger Shipyards Lockport, L.L.C. The highest-conviction signal is the Leidos Biomedical award, which represents a massive, single-source obligation that could indicate a long-term operational contract. A key risk is the lack of pricing and competition data for both awards, which obscures margin and protest risk. The digest highlights a civilian agency spending surge but notes the absence of pure defense contracts, which may signal a shift in federal procurement focus away from DOD in this period.

2 total filings
· daily

Federal Construction & Infrastructure Contracts — June 20, 2026

This digest covers a single $126.8M civilian infrastructure contract awarded by the General Services Administration (GSA) to Ryan Companies US Inc for a new federal courthouse in Des Moines, IA. The contract is entirely civilian, with no defense exposure, and reflects stable GSA investment in federal building modernization. The fixed-price incentive pricing introduces moderate execution risk, though $84.4M has already been outlayed, reducing future funding uncertainty. The neutral signal strength (6/10) and full-and-open competition suggest a competitive win without a clear moat. Key watch items include margin performance on the incentive structure and potential option exercises for scope expansion.

1 total filings
· daily

New Federal Contractors — June 20, 2026

This digest covers four contracts totaling $550.5 million, all awarded by civilian agencies (0% defense-related), with no single contractor receiving multiple awards. The dominant theme is stable, long-duration civilian IT and professional services: Booz Allen Hamilton ($142.9M) and Accenture Federal Services ($141.7M) both secured large CMS and State Department contracts, respectively, providing multi-year revenue visibility. The highest-conviction signal is Booz Allen’s firm-fixed-price CMS win, which represents a durable, competitive win in a stable federal program evaluation market. Key risks include cost-plus pricing suppressing margins at Accenture and potential budget uncertainty for NASA science programs following the PUNCH contract’s upcoming expiry in 2027. With an average signal strength of 5.8/10, this batch offers modest investment insight, weighted toward civilian IT services stability rather than transformative defense growth.

4 total filings
· daily

Significant Contract Modifications ($10M+) — June 20, 2026

This digest covers $550.5 million in significant contract modifications from June 20, 2026, all civilian agency awards with zero defense exposure, reflecting a notable divergence from typical DOD-heavy procurement flows. The dominant theme is stable, multi-year civilian IT and infrastructure spending, with Booz Allen Hamilton's $142.9M CMS PERM contract and Accenture Federal Services' $141.7M State Department data replication award representing the highest-conviction signals for long-term revenue visibility. However, the neutral-to-moderate signal strength (avg 5.8/10) and cost-plus pricing on two of the four contracts temper margin optimism. Key risk: only $41.5M of Accenture's $141.7M obligation has been outlayed, signaling potential funding phasing or execution delays that could pressure near-term cash flows for Novetta Solutions LLC's subsidiary. Investors should monitor CMS budget continuity for the PERM program and NASA's PUNCH mission milestones as catalysts for follow-on awards.

4 total filings
· daily

Contract Deobligations Alert — June 20, 2026

The four contracts analyzed total $550.5 million in obligations, all from civilian agencies, with zero defense-related awards. The dominant theme is civilian IT and infrastructure spending, led by a $142.9M Booz Allen Hamilton contract with CMS for program evaluation (bullish, 7/10 signal strength) and a $141.7M Accenture Federal Services award from the State Department for data replication services. The highest-conviction signal is Booz Allen's long-term revenue visibility through 2028, while key risks include the fixed-price incentive structure on the $126.8M Ryan Companies courthouse contract and the cost-plus pricing on Accenture's award limiting margin upside.

4 total filings
· daily

Contract Option Exercises — June 20, 2026

This digest covers four civilian agency contract option exercises totaling $550.5 million, with zero defense-related awards, underscoring a non-defense procurement focus. The dominant theme is stable, multi-year civilian IT and infrastructure spending, led by a $142.9M CMS award to Booz Allen Hamilton (the sole bullish signal) and a $141.7M State Department data replication contract to Accenture Federal Services. A $139.2M NASA space science contract with Southwest Research Institute and a $126.8M GSA courthouse construction award to Ryan Companies US Inc complete the set. The highest-conviction signal is Booz Allen's competitive win at CMS, providing long-term revenue visibility through 2028. Key risks include margin pressure on Ryan Companies' fixed-price incentive courthouse contract and the phased funding profile of Accenture's cost-plus award.

4 total filings
· daily

Federal Professional Services Contracts — June 20, 2026

The two contracts analyzed total $282.0M in obligations, both from civilian agencies (0% defense), with an average signal strength of 6.0/10. The dominant theme is stable, long-duration civilian professional services, led by a $142.9M Booz Allen Hamilton award from HHS/CMS for program evaluation through 2028, which is the highest-conviction bullish signal. The second award, a $139.2M NASA contract to Southwest Research Institute for space instrumentation, is neutral due to cost-plus pricing and nonprofit status limiting margin upside. Key risks include medium pricing risk on Booz Allen's fixed-price contract and potential budget uncertainty for CMS's PERM program.

2 total filings
· daily

Federal IT & Cybersecurity Contracts — June 20, 2026

The single contract in this digest, a $141.7 million cost-plus-award-fee delivery order awarded to Accenture Federal Services LLC by the Department of State, represents a pure civilian IT services win with no defense exposure. The contract is for data replication engineering and management support through September 2026, but only $41.5 million has been outlayed as of the award date, signaling potential funding phasing or early-stage performance risk. The neutral signal (strength 5/10, materiality 4/10) and low pricing risk suggest a stable but unexciting revenue stream for Accenture Federal Services, with limited upside margin potential due to the cost-plus structure. Key watch items include the outlay rate and any contract modifications near the September 2026 end date.

1 total filings
· daily

All HHS Contracts — June 20, 2026

This digest covers a single, large civilian contract from the Department of Health and Human Services (HHS) to Booz Allen Hamilton Inc., valued at $142.9 million. The award is a firm-fixed-price delivery order under the CMS PERM program, with no defense-related exposure. The highest-conviction signal is bullish, reflecting multi-year revenue visibility through 2028 and a competitive win against peers. Key risks include medium pricing risk on a fixed-price contract and potential budget uncertainty for CMS program integrity funding under a Continuing Resolution. The contract reinforces Booz Allen's strong position in federal health program evaluation services, a stable civilian sector niche.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — June 20, 2026

This digest covers four civilian mega-contracts totaling $550.5M, with zero defense-related awards, highlighting a strong civilian procurement theme. The dominant agencies are HHS/CMS, State, NASA, and GSA, indicating broad-based civilian spending. The highest-conviction signal is Booz Allen Hamilton's $142.9M CMS PERM award, which offers long-term revenue visibility through 2028 and reinforces its competitive position in program evaluation. A key risk is the fixed-price incentive structure on Ryan Companies' $126.8M GSA courthouse contract, which could pressure margins if costs exceed targets.

4 total filings
· daily

High-Value Federal Grants ($5M+) — June 20, 2026

This digest covers four high-value civilian contracts totaling $550.5M, with zero defense-related awards—reflecting a period of robust civilian agency spending rather than Pentagon procurement. The highest-conviction signal is Booz Allen Hamilton's $142.9M CMS PERM contract, a firm-fixed-price award through 2028 offering multi-year revenue visibility. However, three of four contracts use cost-plus or fixed-price incentive structures, capping upside or introducing performance risk. A key watch item is Accenture Federal Services' $141.7M State Department contract, where only $41.5M has been outlayed, suggesting potential funding lags or execution delays. The dominant sector theme is civilian program evaluation and IT services, with Booz Allen and Accenture leading.

4 total filings
· daily

General Federal Contracts — June 20, 2026

This digest covers four federal contracts totaling $550.5 million in obligations, all from civilian agencies with zero defense-related awards. The dominant theme is stable, multi-year professional services and IT support, led by Booz Allen Hamilton’s $142.9M CMS PERM contract (bullish, 7/10 strength) and Accenture Federal Services’ $141.7M State Department data replication award (neutral). The highest-conviction signal is Booz Allen’s long-duration, firm-fixed-price win, signaling recurring revenue and competitive moat in program evaluation. Key risks include cost-plus pricing limiting margin upside for Accenture and Southwest Research Institute, and fixed-price incentive execution risk for Ryan Companies’ courthouse project. Investors should watch CMS budget continuity for PERM and the September 2026 expiration of Accenture’s contract.

4 total filings
· daily

All NASA Contracts — June 20, 2026

The single contract analyzed is a $139.2M NASA award to Southwest Research Institute for the PUNCH instrument concept study, representing a purely civilian space science obligation with no defense exposure. The cost-plus-fixed-fee pricing structure reduces profit volatility but caps upside for the nonprofit contractor, while the 10-year performance period provides long-term revenue visibility averaging $13.9M annually. The neutral signal strength (5/10) reflects stable science funding from a reliable agency, but the lack of a competitive moat indicator and the nonprofit status limits margin expansion potential. Key risks include the extremely narrow sample size, a single-entity concentration, and exposure to NASA's heliophysics budget priorities under potential Continuing Resolutions.

1 total filings